InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Verma Ajay, Director. Director active across 1 company, notably Yumanity Therapeutics, INC.. Aggregated, 1 filings have been logged. Activity tracked since 1 December 2021. The latest transaction was filed on 1 December 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Verma Ajay is Executive Vice President and Head of R&D at Yumanity Therapeutics, Inc. He leads research efforts to develop innovative treatments in the field of neurodegenerative diseases.